Omada Health (NASDAQ:OMDA) President Wei-Li Shao Sells 4,036 Shares

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 4,036 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.85, for a total transaction of $88,186.60. Following the completion of the transaction, the president directly owned 295,313 shares in the company, valued at $6,452,589.05. The trade was a 1.35% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Wei-Li Shao also recently made the following trade(s):

• On Wednesday, August 12th, Wei-Li Shao sold 8,866 shares of Omada Health stock. The shares were sold at an average price of $25.02, for a total transaction of $221,827.32.

Omada Health Stock Performance

NASDAQ OMDA opened at $20.50 on Tuesday. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The company has a fifty day moving average of $22.58 and a 200-day moving average of $18.03. The company has a market capitalization of $1.26 billion, a P/E ratio of 410.00 and a beta of 1.86.

Omada Health (NASDAQ:OMDA) last released its earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The business had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. As a group, analysts forecast that Omada Health, Inc. will post 0.09 EPS for the current fiscal year.

Wall Street Analyst Weigh In

OMDA has been the topic of a number of research reports. JPMorgan Chase & Co. raised their price objective on Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Canaccord Genuity Group upped their target price on Omada Health from $24.00 to $28.00 and gave the stock a “buy” rating in a research note on Tuesday, July 21st. BMO Capital Markets reiterated an “outperform” rating and set a $24.00 price target on shares of Omada Health in a research report on Friday, August 7th. Needham & Company LLC reissued a “buy” rating and set a $28.00 price target on shares of Omada Health in a research note on Friday. Finally, Morgan Stanley restated an “overweight” rating and issued a $30.00 price objective on shares of Omada Health in a report on Monday, June 22nd. Eleven analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $26.67.

Institutional Investors Weigh In On Omada Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. purchased a new stake in Omada Health during the 2nd quarter valued at about $48,775,000. Jefferies Financial Group Inc. purchased a new position in Omada Health in the 4th quarter worth approximately $16,948,000. BIT Capital GmbH increased its stake in Omada Health by 52.4% in the 4th quarter. BIT Capital GmbH now owns 940,238 shares of the company’s stock worth $14,837,000 after purchasing an additional 323,365 shares during the period. Madryn Asset Management LP bought a new stake in Omada Health in the second quarter valued at approximately $12,814,410. Finally, Walleye Capital LLC bought a new stake in Omada Health in the second quarter valued at approximately $11,648,000.

About Omada Health

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.